Showing results (481-490 of 976) with videos related to
Sort By:
Pageof 98
Scientific Reports|October 5, 2013
Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imagingXiaohui Liu, Jennifer L Ide, Isaiah Norton, et al.Nature Genetics|April 8, 2015
Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shorteningBridget D Stuart, Jungmin Choi, Samir Zaidi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
RAF265 inhibits the growth of advanced human melanoma tumorsYingjun Su, Anna E Vilgelm, Mark C Kelley, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant MelanomaJean-Pierre Delord, Caroline Robert, Marta Nyakas, et al.Journal of Synchrotron Radiation|May 5, 2022
Use of diamond sensors for a high-flux, high-rate X-ray pass-through diagnosticJ Bohon, E Gonzalez, C Grace, et al.Molecular Cancer Therapeutics|August 24, 2019
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant CancersHuai-Xiang Hao, Hongyun Wang, Chen Liu, et al.Nature|September 27, 2013
Integrating abundance and functional traits reveals new global hotspots of fish diversityRick D Stuart-Smith, Amanda E Bates, Jonathan S Lefcheck, et al.Proceedings. Biological Sciences|April 20, 2022
Cross-ocean patterns and processes in fish biodiversity on coral reefs through the lens of eDNA metabarcodingLaetitia Mathon, Virginie Marques, David Mouillot, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20-Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer ModelsRaymond A Pagliarini, Jack A Henderson, Benjamin C Milgram, et al.Cancer Research|January 19, 2018
Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAFWenlin Shao, Yuji M Mishina, Yun Feng, et al.Pageof 98